Manage your formulary budget
Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Find generic entry opportunities
Drug patents …
… from Kazakhstan to Kalamazoo
Proactively manage your pharmacy inventory
Anticipate generic drug launch
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Methods for selecting and using gases as ultrasound contrast media|
|Abstract:||Disclosed herein are agents for enhancing the contrast in an ultrasound image. These agents are extremely small bubbles, or "microbubbles," comprised of specially selected gases. The microbubbles described herein exhibit long life spans in solution and may be produced at a size small enough to traverse the lungs, thus enabling improved ultrasound imaging of the cardiovascular system and other vital organs. Also disclosed herein is a method for selecting gases from which contrast agents may be produced. The method is based on calculations using inherent physical properties of gases and describes a means to associate the properties of a gas with the time for dissolution of a microbubble comprised of the gas.|
|Inventor(s):||Quay; Steven C. (Los Angeles, CA)|
|Assignee:||Sonus Pharmaceuticals Inc. (Costa Mesa, CA)|
|Filing Date:||Jun 04, 1993|
|Claims:||1. In a method comprising ultrasound imaging, the improvement comprising enhancing the contrast in an ultrasound image by selecting for use as an enhancing agent free gas microbubbles of a biocompatible fluorocarbon containing contrast-enhancing chemical, |
said chemical as a gas having a Q coefficient greater than 30, where Q is the ratio of the persistence of microbubbles of said gas in an aqueous solution to the persistence of microbubbles of air in said solution.
2. The method of claim 1 wherein the gas is hexafluoropropylene.
3. The method of claim 1 wherein the gas is octafluoropropane.
4. The method of claim 1 wherein the gas is hexafluoroethane.
5. The method of claim 1 wherein the gas is octafluoro-2-butene.
6. The method of claim 1 wherein the gas is hexafluoro-2-butyne.
7. The method of claim 1 wherein the gas is hexafluorobuta-1,3-diene.
8. The method of claim 1 wherein the gas is octafluorocyclobutane.
9. The method of claim 1 wherein the gas is decafluorobutane.
10. The method of claim 1 wherein the microbubbles are present in an aqueous sorbitol solution.
11. The method of claim 1 wherein the microbubbles are present in a solution to which a biocompatible substance has been added to increase the viscosity of the solution.
12. The method of claim 1 wherein the microbubbles are smaller than 8 microns.
13. In a method of ultrasound imaging, the improvement comprising the steps of:
providing a suspension of biocompatible free gas microbubbles of sulfur hexafluoride to an organism to be imaged; and
subjecting said organism to an ultrasound scan.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.